Today, we’re at the forefront of the protein degradation platform. This innovative and effective approach uses a specific protein (ubiquitin E3 ligase) to target and help destroy disease-causing proteins. We are one of only a few leading global companies in this field.
DRUG DISCOVERY USING PROTEIN DEGRADATION AT SEED
For more details, please go to BeyondSpring Subsidiary Seed Therapeutics.